301 related articles for article (PubMed ID: 12971806)
21. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
22. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity.
Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y
Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159
[TBL] [Abstract][Full Text] [Related]
23. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
24. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
[TBL] [Abstract][Full Text] [Related]
25. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine.
Zhu JQ; Zhang LS; Hu X; Xiao Y; Chen JS; Xu YC; Fremy J; Chu FS
Cancer Res; 1987 Apr; 47(7):1848-52. PubMed ID: 3102051
[TBL] [Abstract][Full Text] [Related]
26. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
27. Assessment of aflatoxin exposure using serum and urinary biomarkers in São Paulo, Brazil: A pilot study.
Jager AV; Tonin FG; Baptista GZ; Souto PC; Oliveira CA
Int J Hyg Environ Health; 2016 May; 219(3):294-300. PubMed ID: 26740158
[TBL] [Abstract][Full Text] [Related]
28. Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.
Holeski CJ; Eaton DL; Monroe DH; Bellamy GM
Xenobiotica; 1987 Feb; 17(2):139-53. PubMed ID: 3105186
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of aflatoxin B1-N7-guanine adduct in urine by enzyme-linked immunosorbent assay coupled with immunoaffinity chromatography.
Vidyasagar T; Vyjayanthi V; Sujatha N; Rao BS; Bhat RV
J AOAC Int; 1997; 80(5):1013-22. PubMed ID: 9325579
[TBL] [Abstract][Full Text] [Related]
30. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
31. Aflatoxin M1 effects on Xenopus laevis development.
Vismara C; Di Muzio A; Tarca S; Lucchino M; Foti I; Caloni F
Birth Defects Res B Dev Reprod Toxicol; 2006 Jun; 77(3):234-7. PubMed ID: 16767754
[TBL] [Abstract][Full Text] [Related]
32. Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
Yen CH; Hung JH; Ueng YF; Liu SP; Chen SY; Liu HH; Chou TY; Tsai TF; Darbha R; Hsieh LL; Chen YM
Toxicol Appl Pharmacol; 2009 Mar; 235(3):296-304. PubMed ID: 19146867
[TBL] [Abstract][Full Text] [Related]
33. 7-Alkylguanine adduct levels in urine, lungs and liver of mice exposed to styrene by inhalation.
Vodicka PE; Linhart I; Novak J; Koskinen M; Vodickova L; Hemminki K
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):1-8. PubMed ID: 15949832
[TBL] [Abstract][Full Text] [Related]
34. Thermal stabilization of the DNA duplex by adducts of aflatoxin B1.
Giri I; Stone MP
Biopolymers; 2002 Nov; 65(3):190-201. PubMed ID: 12228924
[TBL] [Abstract][Full Text] [Related]
35. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
Croy RG; Wogan GN
Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
[TBL] [Abstract][Full Text] [Related]
36. Cancer risks posed by aflatoxin M1.
Hsieh DP; Cullen JM; Hsieh LS; Shao Y; Ruebner BH
Princess Takamatsu Symp; 1985; 16():57-65. PubMed ID: 3939566
[TBL] [Abstract][Full Text] [Related]
37. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.
Croy RG; Wogan GN
J Natl Cancer Inst; 1981 Apr; 66(4):761-8. PubMed ID: 6939922
[TBL] [Abstract][Full Text] [Related]
38. Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex.
Fiala JL; Egner PA; Wiriyachan N; Ruchirawat M; Kensler KH; Wogan GN; Groopman JD; Croy RG; Essigmann JM
Toxicol Sci; 2011 May; 121(1):57-62. PubMed ID: 21278056
[TBL] [Abstract][Full Text] [Related]
39. In vitro study of AFB1 and AFM1 effects on human lymphoblastoid Jurkat T-cell model.
Luongo D; Russo R; Balestrieri A; Marzocco S; Bergamo P; Severino L
J Immunotoxicol; 2014 Oct; 11(4):353-8. PubMed ID: 24147459
[TBL] [Abstract][Full Text] [Related]
40. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
Autrup H; Seremet T; Wakhisi J; Wasunna A
Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
